Table 2.
Left: Comparison of the number of Morphine Milligram Equivalents prescribed at 2 years post-operatively amongst Opioid Risk Tool categories. Data is presented as “Average (Standard Deviation)” within each cell; Right: Spearman’s correlation testing of numeric Opioid Risk Tool score and number of Morphine Milligram Equivalents prescribed within 2 years following surgery
| FULL COHORT |
Low Risk
(N=119) |
Moderate Risk
(N=9) |
High Risk
(N=9) |
P Value | Spearman’s Rho | Relationship | |
|---|---|---|---|---|---|---|---|
| MME | 6115 (19684) | 1098 (1209) | 2136 (2391) | 0.734 | 0.112 | No Relationship | |
| PRIOR OPIOID USE COHORT |
Low Risk
(N=30) |
Moderate Risk
(N=2) |
High Risk
(N=5) |
P Value | Spearman’s Rho | Relationship | |
| MME | 15250 (32328) | 675 (0) | 2658 (2802) | 0.690 | -0.003 | No Relationship | |
| NO PRIOR OPIOID USE COHORT |
Low Risk
(N=89) |
Moderate Risk
(N=7) |
High Risk
(N=4) |
P Value | Spearman’s Rho | Relationship | |
| MME | 1648 (4499) | 1182 (1332) | 1091 (1331) | 0.961 | 0.079 | No Relationship |